Search Results 1-10 of 16741 for intestinal metaplasia

  1. Gastrointestinal Neoplasia Clinic - Overview

    Gastrointestinal stromal tumors (GISTs); Gastric intestinal metaplasia; Lymphoma of colon or rectum; Melanoma of the GI tract; Uncommon neoplasms of the stomach ...

  2. Mayo Clinic Q and A: Determining foods to avoid when managing Barrett's esophagus

    That means the normal cells of the esophagus, called “squamous cells,” are replaced by intestinal cells. “Metaplasia” means the replacement of one cell by ...

  3. Barrett's esophagus - Symptoms and causes - Mayo Clinic

    Frequent heartburn and regurgitation of stomach contents; Difficulty swallowing food; Less commonly, chest pain. Curiously, approximately half of the people ...

  4. Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus with Radiofrequency Ablation - Mayo Clinic

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

  5. Assessing the timeline, location and patterns of recurrence in patients achieving complete remission after radiofrequency ablation - Mayo Clinic

    Treatment with RFA and resection can reduce the risk of cancer progression and induce complete remission of intestinal metaplasia (CRIM), both endoscopically ...

  6. Stomach cancer - Symptoms and causes - Mayo Clinic

    Stomach cancer, which is also called gastric cancer, is cancer that begins in the stomach. Learn about symptoms, causes, detection and treatments.

  7. A Study to Evaluate Bile Acid Reflux in Patients with Recurrent Barrett’s Esophagus - Mayo Clinic

    ... intestinal metaplasia, dysplasia, or EAC versus patients who achieved complete remission for at least > 1 year following initial endoscopic intervention ...

  8. Barrett's Esophagus Clinical Trials

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

  9. Barrett's Esophagus Clinical Trials

    This study is designed to evaluate the effect of dexlansoprazole QD and BID dosing on the recurrence of intestinal metaplasia (IM) in subjects who achieved ...

  10. centers-of-excellence

    Search Results 4831-4840 of 8376. Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved ...